Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

GNLX Company Profile and Key Details

NASDAQ : GNLX

Genelux Corporation

$2.63
0.06+2.33%
At Close 4:00 PM
60.65
ESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Genelux Corporation (GNLX) stock surged +2.33%, trading at $2.63 on NASDAQ, up from the previous close of $2.57. The stock opened at $2.57, fluctuating between $2.55 and $2.67 in the recent session.

Stock Snapshot

2.57
Prev. Close
2.57
Open
99.23M
Market Cap
37.73M
Number of Shares
2.55
Day Low
2.67
Day High
-2.77
P/E Ratio
86.98%
Free Float in %
-0.95
EPS (TTM)
0.73
Book Value
-0.8
Cash Flow per Share
59.8K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 17, 20252.572.672.552.6359.63K
Apr 16, 20252.442.582.362.5787.64K
Apr 15, 20252.402.512.302.46119.01K
Apr 14, 20252.502.682.412.42157.6K
Apr 11, 20252.352.482.212.46183.61K
Apr 10, 20252.302.482.272.34371.07K
Apr 09, 20252.082.401.992.31405.04K
Apr 08, 20252.242.292.052.08264.28K
Apr 07, 20252.292.292.072.16295.72K
Apr 04, 20252.482.552.332.39321.05K
Apr 03, 20252.522.562.352.50236.01K
Apr 02, 20252.562.752.542.56186.96K
Apr 01, 20252.902.922.522.60238.58K
Mar 31, 20253.003.152.702.70247.28K
Mar 28, 20253.043.352.943.08203.03K
Mar 27, 20253.163.202.943.03203.1K
Mar 26, 20253.303.523.113.20339.25K
Mar 25, 20253.503.593.033.40573.71K
Mar 24, 20253.963.963.713.8968.9K
Mar 21, 20253.914.023.763.9393.1K

Contact Details

Westlake Village, CA 91361

United States

Website: https://www.genelux.comContact: 858 483 0024

About Company

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.

Company Information

Employees24
Beta-0.4
Sales or Revenue$170.00K
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Genelux Corporation (GNLX) stock price?
Genelux Corporation (NASDAQ: GNLX) stock price is $2.63 in the last trading session. During the trading session, GNLX stock reached the peak price of $2.67 while $2.55 was the lowest point it dropped to. The percentage change in GNLX stock occurred in the recent session was 2.33% while the dollar amount for the price change in GNLX stock was $0.06.
GNLX's industry and sector of operation?
The NASDAQ listed GNLX is part of Biotechnology industry that operates in the broader Healthcare sector. Genelux Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of GNLX?
Mr. Ralph Smalling B.Sc.
Head of Regulatory Affairs
Prof. Paul Scigalla M.D., Ph.D.
Chief Medical Officer
Mr. Thomas Zindrick J.D.
Chairman, Chief Executive Officer & Pres
Ms. Caroline Jewett
Head of Quality
Dr. Joseph Cappello Ph.D.
Chief Technical Officer
Dr. Yong Yu Ph.D.
Senior Vice President of Clinical Devel.
Mr. Sean Ryder J.D.
Gen. Counsel & Corporation Sec.
How GNLX did perform over past 52-week?
GNLX's closing price is 64.38% higher than its 52-week low of $1.60 where as its distance from 52-week high of $5.89 is -55.31%.
How many employees does GNLX have?
Number of GNLX employees currently stands at 24.
Link for GNLX official website?
Official Website of GNLX is: https://www.genelux.com
How do I contact GNLX?
GNLX could be contacted at phone 858 483 0024 and can also be accessed through its website. GNLX operates from 2625 Townsgate Road, Westlake Village, CA 91361, United States.
How many shares of GNLX are traded daily?
GNLX stock volume for the day was 59.8K shares. The average number of GNLX shares traded daily for last 3 months was 242.74K.
What is the market cap of GNLX currently?
The market value of GNLX currently stands at $99.23M with its latest stock price at $2.63 and 37.73M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph